Cargando…

Treatment of the low bone mineral density with intravenous pamidronate in pediatric patients: review of a protocol of a single-day infusion twice a year

Detalles Bibliográficos
Autores principales:	Ricart, S, Anton, J, del Rio, M, Ros, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333929/ http://dx.doi.org/10.1186/1546-0096-6-S1-P132

Ejemplares similares

Treatment of osteogenesis imperfecta with intravenous pamidronate in pediatric patients: comparison between a single-day infusion twice a year protocol with other regimens described in the literature
por: Ricart, S, et al.
Publicado: (2008)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
por: Lim, Se Won, et al.
Publicado: (2016)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
por: Yoon, Ji-Hee, et al.
Publicado: (2021)

Intravenous Pamidronate for Refractory Lymphedema
por: Beigi, A A, et al.
Publicado: (2011)

Effects of Adding Intravenous Pamidronate to Ongoing Menopausal Hormone Therapy in Postmenopausal Korean Women with Low Bone Mineral Density
por: Koo, Young-Ah, et al.
Publicado: (2019)

Intravenous pamidronate for refractory rheumatoid arthritis
por: Salesi, Mansour, et al.
Publicado: (2012)

High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Height and weight development following cyclical intravenous pamidronate in children and adolescents with chronic recurrent multifocal osteomyelitis (CRMO)
por: Miettunen, PM, et al.
Publicado: (2008)

Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Lim, Mie Jin, et al.
Publicado: (2010)

PReS-FINAL-2229: Pamidronate in CRMO - a small case series
por: Schuller, M, et al.
Publicado: (2013)

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
por: Chantzichristos, Dimitrios, et al.
Publicado: (2008)

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
por: Salesi, Mansour, et al.
Publicado: (2011)

Short-term Efficacy of Monthly Pamidronate Infusion in Patients with Osteogenesis Imperfecta
por: Choi, Jin-Ho, et al.
Publicado: (2007)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
por: Purohit, O. P., et al.
Publicado: (1995)

Therapy with teicoplanin in the ICU: continuous intravenous infusion or intermittent intravenous administration?
por: Nardi, E, et al.
Publicado: (2008)

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).
por: Ling, P. J., et al.
Publicado: (1995)

PReS-FINAL-2275: Improvement of calcinosis cutis with intravenous pamidronate in a 2-year-old girl with progressive widespread skin calcification of unknown origin
por: Mrusek, S, et al.
Publicado: (2013)

Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Marcuzzi, Annalisa, et al.
Publicado: (2011)

The Author Response: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis
por: Park, Won
Publicado: (2011)

Pamidronate treatment in resistant cases of CRMO – our small case series
por: Vrtíková, Eva, et al.
Publicado: (2014)

Chronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate)
por: Teruzzi, B, et al.
Publicado: (2008)

Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma
por: Lee, Jae Min, et al.
Publicado: (2013)

ODP094 Hypercalcemia caused by Mycobacterium Avium Complex, with Excellent Response to Intravenous Pamidronate.
por: Khthir, Rodhan
Publicado: (2022)

Succesful treatment of diffuse sclerosing osteomyelitis of the mandible/mandibular chronic non-bacterial osteitis with intravenous pamidronate: resolution of pain and radiographic bone inflammation with improved cosmetic appearance - a case study
por: Miettunen, Paivi, et al.
Publicado: (2014)

Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates
por: Eekman, Danielle A, et al.
Publicado: (2009)

Amphotericin B used as a continuous infusion is safer
por: Streefkerk, J, et al.
Publicado: (2010)

Identification of predictors of bone mineral density trajectories in pediatric Systemic Lupus Erythematosus patients
por: Lim, SHL, et al.
Publicado: (2011)

Pamidronate “zebra lines”: A treatment timeline
por: Loizidou, Avgi, et al.
Publicado: (2017)

The Neurological Safety of Epidural Pamidronate in Rats
por: Lee, Pyung Bok, et al.
Publicado: (2010)

Therapy with pamidronate in children with osteogenesis imperfecta
por: Marginean, Otilia, et al.
Publicado: (2017)

Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
por: Morbach, H, et al.
Publicado: (2015)

Evaluation of the effect of guidelines to reduce intravenous potassium infusions in ICU patients
por: Min, MC Law, et al.
Publicado: (2015)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Lithotomy Performed Twice in Three Days on the Same Patient
por: Dupuytren, M.
Publicado: (1829)

Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients
por: Pin, Fabrizio, et al.
Publicado: (2019)

Bone mineral density in elite rowers
por: Lundy, Bronwen, et al.
Publicado: (2015)

Dihydrotachysterol intoxication treated with pamidronate: a case report
por: Jensterle, Mojca, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_hejc4kb00huk04e6b40jr6a7rs